The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Alafi Moshe since 2005.
The trader's CIK number is 1008890.
At the time of the last reporting, Alafi Moshe was the 10% Owner of Intra-cellular Therapies, Inc.. (stock ticker symbol ITCI).
Also see all insider trading activities at Intra-cellular Therapies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ITCI | 258,065 | $4,000,007 | 0 | $0 | 0 | $0 |
| 2016 | ITCI | 99,000 | $1,550,463 | 0 | $0 | 0 | $0 |
| 2014 | ITCI | 53,320 | $791,372 | 15,742 | $100,008 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | STXS | 10,000 | $108,900 | 0 | $0 | 0 | $0 |
| 2005 | STXS | 32,102 | $228,694 | 0 | $0 | 0 | $0 |
1. Intra-cellular Therapies, Inc. (ITCI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-10-02 | ITCI | Buy | 258,065 | 15.50 | 4,000,007 |
| 2016-12-06 | ITCI | Buy | 44,174 | 16.33 | 721,449 |
| 2016-12-07 | ITCI | Buy | 20,826 | 16.14 | 336,048 |
| 2016-11-14 | ITCI | Buy | 34,000 | 14.50 | 492,966 |
| 2014-12-01 | ITCI | Buy | 1,422 | 14.75 | 20,974 |
| 2014-11-28 | ITCI | Buy | 35,000 | 14.75 | 516,250 |
| 2014-11-19 | ITCI | Buy | 1,034 | 14.25 | 14,734 |
| 2014-11-14 | ITCI | Buy | 133 | 15.07 | 2,004 |
| 2014-11-18 | ITCI | Buy | 3,531 | 14.23 | 50,246 |
| 2014-11-11 | ITCI | Buy | 5,000 | 15.55 | 77,750 |
| 2014-11-12 | ITCI | Buy | 5,000 | 15.23 | 76,150 |
| 2014-11-13 | ITCI | Buy | 2,200 | 15.12 | 33,264 |
| 2014-06-19 | ITCI | Sale | 15,742 | 6.35 | 100,008 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-03-15 | STXS | Buy | 10,000 | 10.89 | 108,900 |
| 2005-12-06 | STXS | Buy | 32,102 | 7.12 | 228,694 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alafi Moshe (10% Owner of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.